0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Sign in to save

Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer

Theranostics 2022 88 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 60 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Javeria Zaheer, Javeria Zaheer, Hyeongi Kim, Javeria Zaheer, Javeria Zaheer, Hyeongi Kim, Javeria Zaheer, Javeria Zaheer, Javeria Zaheer, Hyeongi Kim, Jin Su Kim Hyeongi Kim, Javeria Zaheer, Eui‐Ju Choi, Jin Su Kim Javeria Zaheer, Jin Su Kim Eui‐Ju Choi, Jin Su Kim Jin Su Kim Jin Su Kim Hyeongi Kim, Jin Su Kim Jin Su Kim Jin Su Kim Jin Su Kim Jin Su Kim Jin Su Kim Jin Su Kim

Summary

Researchers fed polystyrene microplastics to mice and found that the particles accumulated in stomach tissue, where they triggered changes associated with more aggressive cancer behavior. In gastric cancer cells, microplastic exposure increased migration, induced drug resistance to multiple cancer therapies, and activated a gene called ASGR2 that appears to drive these effects. The study suggests that microplastic accumulation in the stomach may interfere with the effectiveness of cancer treatments.

Polymers
Study Type In vivo

<b>Background:</b> Microplastics (MPs) are a new global environmental threat. Previously, we showed the biodistribution of MPs using [<sup>64</sup>Cu] polystyrene (PS) and PET in mice. Here, we aimed to identify whether PS exposure has malignant effects on the stomach and induces resistance to therapy. <b>Methods:</b> BALB/c nude mice were fed 1.72 × 10<sup>4</sup> particles/mL of MP. We investigated PS accumulation in the stomach using radioisotope-labeled and fluorescent-conjugated PS. Further, we evaluated whether PS exposure induced cancer stemness and multidrug resistance, and whether it affected tumor development, tumor growth, and survival rate <i>in vivo</i> using a 4-week PS-exposed NCI-N87 mouse model. Using RNA-Seq analysis, we analyzed whether PS exposure induced gene expression changes in gastric tissues of mice. <b>Results:</b> PET imaging results showed that a single dose of [<sup>64</sup>Cu]-PS remained for 24 h in the mice stomach. The 4-week daily repetitive dose of fluorescent conjugated PS was deposited in the gastric tissues of mice. When PS was exposed, a 2.9-fold increase in migration rate was observed for NCI-N87 cells. Immunocytochemistry results showed decreased E-cadherin and increased N-cadherin expression, and flow cytometry, qPCR, and western blot analysis indicated a 1.9-fold increase in N-cadherin expression after PS exposure<b>.</b> Further, PS-induced multidrug resistance to bortezomib, paclitaxel, gefitinib, lapatinib, and trastuzumab was observed in the NCI-N87 mouse model due to upregulated CD44 expression. RNA-seq results identified increased asialoglycoprotein receptor 2 (<i>ASGR2</i>) expression after PS exposure, and <i>ASGR2</i> knockdown decreased cell proliferation, migration, invasion, and drug resistance. <b>Conclusion:</b> We demonstrated that <i>ASGR2</i> enhanced cancer hallmarks on PS exposure and induced resistance to chemo- and monoclonal antibody-therapy. Our preclinical findings may provide an incentive for further epidemiological studies on the role of MP exposure and its association with gastric cancer.

Sign in to start a discussion.

Share this paper